News on Hemic_And_Immune_Systems from BioPortfolio.com http://www.BioPortfolio.com Consolidated Hemic_And_Immune_Systems news from BioPortfolio.com Wed, 10 Feb 2010 05:51:03 GMT en Ligon Discovery and Lycera Collaborate to Develop First-in-Class Drugs for Immune Disordershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037759&HITNO=0&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037759&THISHREF=http://c.moreover.com/click/here.pl%3fz2537270863%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037759&HITNO=0&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037759&THISHREF=http://c.moreover.com/click/here.pl%3fz2537270863%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Exploring the physiology of ageing - part 9: The immune systemhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037674&HITNO=1&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037674&THISHREF=http://c.moreover.com/click/here.pl%3fz2537235638%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037674&HITNO=1&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037674&THISHREF=http://c.moreover.com/click/here.pl%3fz2537235638%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNursing Times: Ligon Discovery and Lycera Collaborate to Develop First-in-Class Drugs for Immune Disordershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037637&HITNO=2&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037637&THISHREF=http://c.moreover.com/click/here.pl%3fz2537198799%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037637&HITNO=2&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037637&THISHREF=http://c.moreover.com/click/here.pl%3fz2537198799%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Ligon Discovery and Lycera Collaborate to Develop First-in-Class Drugs for Immune Disordershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037588&HITNO=3&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037588&THISHREF=http://c.moreover.com/click/here.pl%3fz2537162932%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037588&HITNO=3&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037588&THISHREF=http://c.moreover.com/click/here.pl%3fz2537162932%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Ligon Discovery and Lycera Collaborate to Develop First-in-Class Drugs for Immune Disordershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037547&HITNO=4&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037547&THISHREF=http://c.moreover.com/click/here.pl%3fz2537138965%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037547&HITNO=4&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037547&THISHREF=http://c.moreover.com/click/here.pl%3fz2537138965%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Impact on Allergic Immune Response After Treatment With Vitamin Ahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036624&HITNO=5&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036624&THISHREF=http://c.moreover.com/click/here.pl%3fz2536688545%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036624&HITNO=5&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036624&THISHREF=http://c.moreover.com/click/here.pl%3fz2536688545%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedscape: Risk of Leukoencephalopathy Increases as the Number of Natalizumab Infusions Increaseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036486&HITNO=6&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036486&THISHREF=http://c.moreover.com/click/here.pl%3fz2536632640%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036486&HITNO=6&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036486&THISHREF=http://c.moreover.com/click/here.pl%3fz2536632640%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotechnology Healthcare: An Early Warning System for Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033668&HITNO=7&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033668&THISHREF=http://c.moreover.com/click/here.pl%3fz2535314816%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033668&HITNO=7&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033668&THISHREF=http://c.moreover.com/click/here.pl%3fz2535314816%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTechnology Review: Whittemore Peterson Institute Announces Renowned Health Expert as New Spokespersonhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033096&HITNO=8&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033096&THISHREF=http://c.moreover.com/click/here.pl%3fz2535007200%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033096&HITNO=8&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033096&THISHREF=http://c.moreover.com/click/here.pl%3fz2535007200%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Perinatal HBV Transmission May Occur Despite Newborn Vaccination and Immune Globulinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032914&HITNO=9&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032914&THISHREF=http://c.moreover.com/click/here.pl%3fz2534878241%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032914&HITNO=9&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032914&THISHREF=http://c.moreover.com/click/here.pl%3fz2534878241%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHIV and Hepatitis.com: Biotech ETFs Immune To Broad Sellinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032787&HITNO=10&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032787&THISHREF=http://c.moreover.com/click/here.pl%3fz2534822383%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032787&HITNO=10&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032787&THISHREF=http://c.moreover.com/click/here.pl%3fz2534822383%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInvestors Business Daily: Biotech ETFs Immune To Broad Sellinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032564&HITNO=11&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032564&THISHREF=http://c.moreover.com/click/here.pl%3fz2534705719%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032564&HITNO=11&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032564&THISHREF=http://c.moreover.com/click/here.pl%3fz2534705719%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Effects of Tesamorelin, a Growth Hormone-Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension - pdf attachedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031864&HITNO=12&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031864&THISHREF=http://c.moreover.com/click/here.pl%3fz2534400599%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031864&HITNO=12&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031864&THISHREF=http://c.moreover.com/click/here.pl%3fz2534400599%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNational AIDS Treatment Advocacy Project: ::: Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Thttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031489&HITNO=13&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031489&THISHREF=http://c.moreover.com/click/here.pl%3fz2534231024%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031489&HITNO=13&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031489&THISHREF=http://c.moreover.com/click/here.pl%3fz2534231024%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotech Intelligence: Vision loss affecting one in ten Ugandan people with HIVhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030675&HITNO=14&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030675&THISHREF=http://c.moreover.com/click/here.pl%3fz2533757263%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030675&HITNO=14&MSIZE=352&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hemic_And_Immune_Systems&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030675&THISHREF=http://c.moreover.com/click/here.pl%3fz2533757263%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAidsmap: